cbm 4a has been researched along with Neoplasm Metastasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bieblová, J; Bubeník, J; Indrová, M; Jandlová, T; Jinoch, P; Mendoza, L; Mikysková, R; Pajtasz-Piasecka, E; Símová, J; Smahel, M; Vonka, V | 1 |
1 other study(ies) available for cbm 4a and Neoplasm Metastasis
Article | Year |
---|---|
Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
Topics: Adjuvants, Immunologic; Animals; Antigens, Neoplasm; Antineoplastic Agents, Alkylating; Cancer Vaccines; Cell Transformation, Viral; Combined Modality Therapy; Drug Screening Assays, Antitumor; Genes, MHC Class I; Genes, ras; Granulocyte-Macrophage Colony-Stimulating Factor; Histocompatibility Antigens Class I; Ifosfamide; Immunotherapy; Injections, Subcutaneous; Interleukin-12; Interleukin-2; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Repressor Proteins; Vaccination | 2003 |